NCT00774696View on ClinicalTrials.gov

Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

February 28, 2003

Conditions
Healthy
Interventions
DRUG

clarithromycin 500mg tablets

Trial Locations (1)

63301

Gateway Medical Research Inc., Saint Charles

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00774696 - Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter